» Articles » PMID: 26020519

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries

Overview
Journal PLoS One
Date 2015 May 29
PMID 26020519
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Triple-negative breast cancer (TNBC) has been demonstrated to carry poor prognosis, but whether or not there exists any age-related variation in TNBC outcomes has yet to be elucidated. The current population-based study investigated the early survival pattern of elderly women with TNBC and identified outcome-correlated factors.

Patients And Methods: We searched the Surveillance, Epidemiology, and End Results (SEER) database and enrolled female primary non-metastatic TNBC cases. The patients were subdivided into elderly (≥70 years) and young groups (<70 years). The survival status of elderly patients was compared to that of the younger women. The primary and secondary endpoints were cancer-specific survival (CSS) and overall survival (OS) respectively.

Results: 9908 female TNBC patients diagnosed from 2010 to 2011 were included in the current study (20.4% elderly). Elderly patients with relatively advanced diseases exhibited distinctly worse cancer-specific (log-rank, p<0.001) and overall survival (log-rank, p<0.001) than their young counterparts. Advanced age at diagnosis (≥70 years) was significantly predictive of poor outcome in terms of CSS (hazard ratio (HR), 2.125; 95% confidence interval (CI), 1.664 to 2.713; p<0.001) and OS (HR, 3.042; 95%CI, 2.474 to 3.740; p<0.001). Underuse of curative treatment especially radiotherapy was more prevalent in elderly women with stage II or III diseases than in younger patients.

Conclusion: Elderly patients with TNBC displayed elevated early mortality within the first two years of diagnosis compared to the younger individuals. The observed lower rate of loco-regional treatment might be associated with worse cancer-specific outcome for these patients.

Citing Articles

Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.

Earla J, Kurian A, Kponee-Shovein K, Mahendran M, Song Y, Hua Q Adv Ther. 2024; 42(2):886-903.

PMID: 39680314 PMC: 11787175. DOI: 10.1007/s12325-024-03074-7.


Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?.

Record S, Thomas S, Dalton J, van den Bruele A, Chiba A, DiLalla G Ann Surg Oncol. 2024; 31(13):8802-8812.

PMID: 39198350 PMC: 11900900. DOI: 10.1245/s10434-024-16106-x.


Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort.

Qiu Y, Chen Y, Shen H, Yan S, Li J, Wu W Front Oncol. 2024; 14:1388869.

PMID: 38919536 PMC: 11197398. DOI: 10.3389/fonc.2024.1388869.


Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis.

Kesireddy M, Elsayed L, Shostrom V, Agarwal P, Asif S, Yellala A Cancers (Basel). 2024; 16(10).

PMID: 38791870 PMC: 11120599. DOI: 10.3390/cancers16101791.


Disparities in care of older adults of color with cancer: A narrative review.

Dotan E, Lynch S, Ryan J, Mitchell E Cancer Med. 2024; 13(3):e6790.

PMID: 38234214 PMC: 10905558. DOI: 10.1002/cam4.6790.


References
1.
Rocco N, Rispoli C, Pagano G, Rengo G, Compagna R, Danzi M . Breast cancer surgery in elderly patients: postoperative complications and survival. BMC Surg. 2013; 13 Suppl 2:S25. PMC: 3851160. DOI: 10.1186/1471-2482-13-S2-S25. View

2.
Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P . Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003; 21(19):3580-7. DOI: 10.1200/JCO.2003.02.046. View

3.
Yu K, Li J, Di G, Wu J, Shen Z, Shao Z . A straightforward but not piecewise relationship between age and lymph node status in Chinese breast cancer patients. PLoS One. 2010; 5(6):e11035. PMC: 2882951. DOI: 10.1371/journal.pone.0011035. View

4.
Reis-Filho J, Tutt A . Triple negative tumours: a critical review. Histopathology. 2008; 52(1):108-18. DOI: 10.1111/j.1365-2559.2007.02889.x. View

5.
Bauer K, Brown M, Cress R, Parise C, Caggiano V . Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007; 109(9):1721-8. DOI: 10.1002/cncr.22618. View